Abbott Laboratories (ABT) Gross Margin (2009 - 2026)

Abbott Laboratories has disclosed Gross Margin across 18 years of filings, most recently posting 57.71% for Q2 2026.

• In Q2 2026, Gross Margin rose 128.0% year-over-year to 57.71%; the TTM figure through Jun 2026 stood at 56.61% (up 60.0% YoY), while the FY2025 annual figure was 56.42%, up 101.0% from the prior year.
• Gross Margin came in at 57.71% for Q2 2026 at Abbott Laboratories, up from 56.2% in the prior quarter.
• In the past five years, Gross Margin ranged from a high of 58.07% in Q1 2022 to a low of 54.48% in Q4 2022.
• Average Gross Margin over 5 years is 55.9%, with a median of 55.6% recorded in 2024.
• The largest YoY upside for Gross Margin was 457 bps in 2022 against a maximum downside of 399 bps in 2022.
• Over 5 years, Gross Margin stood at 54.48% in 2022, then advanced by 2 bps to 55.51% in 2023, then decreased by 1 bps to 54.97% in 2024, then advanced by 4 bps to 57.05% in 2025, then advanced by 1 bps to 57.71% in 2026.
• Per Business Quant data, the three most recent Gross Margin figures were 57.71% in Q2 2026, 56.2% in Q1 2026, and 57.05% in Q4 2025.